Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PDL BIOPHARM INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 147.53 M 437.52 M 333.12 M 284.99 M 390.36 M
    Net Receivables 13.50 M 5.16 M 14.82 M 51.96 M 0.00
    Total Inventories 0.00 0.00 19.66 M 17.73 M 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses — — — — —
    Other Current Assets 19.65 M 277.75 M 11.89 M 27.52 M 9.75 M
    Current Assets Total 180.68 M 720.43 M 379.50 M 382.20 M 400.11 M
    Long Term Receivables 0.00 0.00 0.00 0.00 30.00 M
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 0.00 3.27 M 93.16 M 48.93 M 6.72 M
    Property, Plant & Equipment Net 1.12 M 330.75 M 296.53 M 266.05 M 238.08 M
    Property, Plant & Equipment Gross 9.26 M 409.60 M 382.15 M 321.68 M 278.57 M
    Accumulated Depreciation 8.13 M 78.85 M 85.62 M 55.63 M 40.49 M
    Other Assets 5.42 M 99.42 M 366.63 M 468.82 M 38.82 M
    Deferred Charges 5.40 M 3.00 M 4.70 M 7.00 M 6.60 M
    Tangible Other Assets 25,000.00 5.64 M 6.26 M 6.77 M 916,000.00
    Intangible Other Assets 0.00 90.78 M 355.67 M 455.05 M 31.31 M
    Total Assets 187.23 M 1.15 B 1.14 B 1.17 B 713.73 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 678,000.00 1.24 M 676,000.00 923,000.00
    Accrued Payroll 7.86 M 27.29 M 21.20 M 16.40 M 6.98 M
    Income Taxes Payable 7.34 M 38.32 M 6.08 M 2.83 M —
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 14.60 M 46.90 M 64.07 M 52.26 M 30.63 M
    Current Liabilities Total 31.51 M 122.09 M 106.06 M 74.90 M 43.45 M
    Long Term Debt 500.00 M 534.85 M 536.92 M 507.29 M 257.47 M
    Provision for Risks & Charges 0.00 0.00 0.00 0.00 —
    Deferred Taxes -3.91 M -38.32 M -6.08 M 0.00 0.00
    Deferred Income 1.50 M 27.65 M 31.37 M 57.74 M 0.00
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 10.70 M 0.00 0.00 0.00 301,000.00
    Total Liabilities 539.80 M 646.26 M 668.28 M 639.94 M 301.22 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity -352.57 M 507.61 M 467.54 M 526.06 M 412.51 M
    Common Stock 1.19 M 1.18 M 1.15 M 1.12 M 959,000.00
    Capital Surplus 169.20 M 1.10 B 1.04 B 969.12 M 686.30 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -539,000.00 -858,000.00 -2.00 M — —
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 —
    Retained Earnings -522.96 M -591.34 M -570.13 M -440.11 M -273.53 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 0.00 67,000.00 -468,000.00 -2.07 M -1.22 M
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 187.23 M 1.15 B 1.14 B 1.17 B 713.73 M
    Common Shares Outstanding 119.30 M 141.09 M 138.01 M 134.47 M 115.03 M